Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05514600 · ClinicalTrials.gov registry record · NA

Fascial Defect Closure for Minimally Invasive Parastomal Hernia Repair

A NA study, sponsored by The Cleveland Clinic.

Terminated
Registry status
NA
Development phase
2
Enrollment target

NCT05514600: Clinical Trial NA study, sponsored by The Cleveland Clinic.

NCT05514600 is a NA study that was terminated before completion, run by The Cleveland Clinic. The registered enrollment target is 2 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05514600, a NA study, was terminated before completion, sponsored by The Cleveland Clinic.

TERMINATED
Registry status
NA
Development phase
2 participants
Enrollment target

Study Summary

Fascial closure was not originally a routine component of minimally invasive parastomal hernia repairs, but several recent advancements have made fascial closure more common in this context. These include barbed self-locking sutures that aid intracorporeal fascial closure under tension, and wristed instrumentation offered by the robotic platform when available. The investigator aims to characterize the clinical significance of closing the fascia adjacent to the stoma during a MIS parastomal hernia repair. The investigator hypothesizes that fascial closure will not have a significant impact on postoperative stoma specific quality of life but will reduce long-term recurrence.

Primary Outcome

The investigators will compare stoma-specific quality of life score using the Colostomy Impact Score (a patient reported survey with 7 questions with a range of 0-38 and higher scores indicating more negative impact on quality of life) at 1 year +/-4 months after minimally invasive Sugarbaker parastomal repair with and without parastomal fascial closure.

Interventions

  • PROCEDURE closure of parastomal hernia fascial defect

Trial Details

FieldValue
Enrollment Target 2 participants
Start Date 2022-09-08
Est. Completion 2023-05-20
Phase NA
The Cleveland Clinic

688 total trials

Why NCT05514600 stopped before completion

NCT05514600 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 2 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).

The record links to 0 conditions, and to 1 intervention - of which closure of parastomal hernia fascial defect is the first listed.

NCT05514600 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT05514600 about?

NCT05514600 is a clinical study titled "Fascial Defect Closure for Minimally Invasive Parastomal Hernia Repair". Fascial closure was not originally a routine component of minimally invasive parastomal hernia repairs, but several recent advancements have made fascial closure more common in this context. These include barbed self-locking sutures that aid intracorporeal fascial closure under tension, and wristed ...

What is the current status of trial NCT05514600?

This trial is currently terminated. It is a NA study. The enrollment target is 2 participants. The study started on 2022-09-08. Estimated completion is 2023-05-20.

What interventions are being tested in trial NCT05514600?

The interventions under investigation include: closure of parastomal hernia fascial defect (PROCEDURE).

Who is sponsoring clinical trial NCT05514600?

This trial is sponsored by The Cleveland Clinic, which has 688 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT05514600's enrollment target sits among peer trials

2 1997th of 2000 the lowest of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT05514600, the US trial registry maintained by the National Library of Medicine. NCT05514600 (small enrollment · none site footprint · terminated) retrieved and formatted by PlainTrial, see methodology.